Search Results 1131-1140 of 19357 for hemoglobin

1. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

   Hemoglobin ≥ 10 g/dL. Patient must have the ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria.

2. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ECOG Performance Status grade of 0 or 1. Clinical laboratory values meeting the following criteria during the Screening Phase: HEMOTOLOGY. Hemoglobin. ≥ 8.0 ...

3. Muscle and Adipose Trafficking of Fatty Acids Under Hypoinsulinemic and Fed Conditions - Mayo Clinic

   Normal hemoglobin >11.0 g/dL for women and men will be acceptable. Women of child-bearing potential will complete a urine pregnancy test at each visit.

4. Vitamin deficiency anemia - Diagnosis & treatment - Mayo Clinic

   A lack of folate and vitamin B-12 can cause red blood cells to become too large so they can't carry oxygen well.

5. Oligomets pancreas SBRT - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN (If known Gilbert's ...

6. A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   No cytopenias (platelets < 100,000/µl, hemoglobin < 10 g/dl, or absolute neutrophil count < 1500/µl). Exclusion Criteria: The following criteria will prevent ...

7. Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes - Mayo Clinic

   Subject has Glycosylated hemoglobin (HbA1c) > 8.5 % at time of screening. Note: All HbA1c blood specimens will be sent to and tested by a NGSP certified ...

8. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

   Hemoglobin ≥11.0 g/dL; Aspartate transaminase (AST) 3 x ULN; Creatinine 1.5 X ULN; Total bilirubin ≤1.5 x upper limit of normal (ULN) (or total bilirubin ...

9. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 8.5 g/dL. Adequate other organ functions as defined by the following: Alanine aminotransferase (ALT) and (aspartate aminotransferase) AST ≤ 3x ...

10. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (can be corrected by growth factor or transfusion); Platelet count ≥ 100 x 10^9/L. Adequate blood coagulation function as evidenced by ...